Meikai Chen
Overview
Explore the profile of Meikai Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Y, Chen M, Yang R, Wumaierjiang M, Huang S
Int J Environ Res Public Health
. 2022 Dec;
19(24).
PMID: 36554366
(1) Background: Understanding occurrence can help formulate effective preventative laws and regulations. However, the most recent global burden and road injuries (RIs) trends have not been reported. This study reports...
2.
Liang W, Chen X, Zhang S, Fang J, Chen M, Xu Y, et al.
Cell Mol Biol Lett
. 2021 Jan;
26(1):3.
PMID: 33472580
Mesenchymal stem cells (MSCs) show homing capacity towards tumor sites. Numerous reports indicate that they are involved in multiple tumor-promoting processes through several mechanisms, including immunosuppression; stimulation of angiogenesis; transition...
3.
Zhao X, Li L, Chen M, Xu Y, Zhang S, Chen W, et al.
Curr Top Med Chem
. 2020 Oct;
20(30):2801-2819.
PMID: 33076808
Nanotechnology and its allied modalities have brought revolution in tissue engineering and bone healing. The research on translating the findings of the basic and preclinical research into clinical practice is...
4.
Zhang S, Dong Y, Chen M, Xu Y, Ping J, Chen W, et al.
J Artif Organs
. 2020 Feb;
23(3):191-202.
PMID: 32100147
Recent advances in biomaterial designing techniques offer immense support to tailor biomimetic scaffolds and to engineer the microstructure of biomaterials for triggering bone regeneration in challenging bone defects. The current...
5.
Xu Y, Chen M, Zhang T, Ma Y, Chen X, Zhou P, et al.
Acta Neurobiol Exp (Wars)
. 2019 Dec;
79(4):319-327.
PMID: 31885389
Spinal cord injury (SCI) is traumatic central nervous system damage resulting in a motor and sensory dysfunction that usually causes a severe and permanent paralysis. Today, the treatment of SCI...
6.
Chen M, Xu Y, Zhang T, Ma Y, Liu J, Yuan B, et al.
Biotechnol Lett
. 2019 Jan;
41(3):305-318.
PMID: 30680496
Mesenchymal stem cells (MSCs), a class of adult stem cells, are considered a promising source for bone regeneration. Although combining MSCs with biomaterial scaffolds offers an interesting clinical strategy for...
7.
Chen W, Chen M, Xu Y, Chen X, Zhou P, Zhao X, et al.
Biochem Biophys Res Commun
. 2018 Apr;
499(4):913-919.
PMID: 29626476
Long non-coding RNA (LncRNA) dysregulation is associated with human osteosarcoma (OS) cell progression. Recent studies have characterized a novel but ultra-conserved LncRNA THOR ("Lnc-THOR") as a cancer-specific LncRNA, mediating cell...
8.
Hu X, Wang Z, Chen M, Chen X, Liang W
Biochem Biophys Res Commun
. 2018 Feb;
497(2):499-505.
PMID: 29432734
mTOR over-activation is important for human osteosarcoma (OS) tumorigenesis and progression. RES-529 is a mTORC1/2 dual inhibitor. Here, our results show that RES-529 inhibited viability, cell cycle progression and proliferation...